Prerpints.org logo
Preprint
Review

C. elegans Germline as Three Distinct Tumor Models

Altmetrics

Downloads

111

Views

43

Comments

0

A peer-reviewed article of this preprint also exists.

Submitted:

11 May 2024

Posted:

13 May 2024

You are already at the latest version

Alerts
Abstract
Tumor cells display abnormal growth and division, avoiding the natural process of cell death. These cells can be benign (non-cancerous growth) or malignant (cancerous growth). Over the past few decades, numerous in vitro or in vivo tumor models have been employed to understand the molecular mechanisms associated with tumorigenesis in diverse aspects. However, our comprehension of how non-tumor cells transform into tumor cells at molecular and cellular levels remains incomplete. The nematode C. elegans has emerged as an excellent model organism for exploring various phenomena, including tumorigenesis. Although C. elegans does not naturally develop cancer, it serves as a valuable platform for identifying oncogenes and the underlying mechanisms within a live organism. In this review, we describe three distinct germline tumor models in C. elegans, highlighting their associated mechanisms and related regulators. Given the conservation of many of the regulators implicated in C. elegans tumorigenesis, it is proposed that these unique models hold significant potential for enhancing our comprehension of the broader control mechanisms governing tumorigenesis.
Keywords: 
Subject: Biology and Life Sciences  -   Cell and Developmental Biology

1. Introduction

Tumorigenesis, the abnormal proliferation of cells leading to tumor formation, highlights various capabilities of cancer cells, such as growth signal self-sufficiency, insensitivity to anti-growth signals, apoptosis evasion, replicative potential, sustained angiogenesis, and tissue invasion [1]. Due to the complexity and overlapping genetic changes in humans, model organisms are crucial in studying tumorigenesis. The nematode Caenorhabditis elegans (C. elegans) is a preferred genetic model for in vitro tumorigenesis research. The transparency of C. elegans enables direct observation of cell growth and tumorigenesis in vivo [2]. Its highly conserved genes and pathways related to tumorigenesis make C. elegans an ideal model organism [2], especially for studying tumorigenesis in germline influenced by both germline and somatic signals [2].

1.1. C. elegans Germline Development

C. elegans exist as either hermaphrodites (XX) or males (XO). Hermaphrodites initially produce a limited number of sperm during the larval stage (L4) and then switch to producing oocytes in young adult stages; they are self-fertile during adulthood. However, males consistently produce sperm without switching to oogenesis. The germline is organized in a simple linear pattern in both sexes, progressing from germline stem cells (GSCs) at the distal region to maturing gametes at the proximal region (Figure 1A). Specifically, a mesenchymal somatic cell, known as the distal tip cell (DTC), functions as a GSC niche and plays a crucial role in GSC maintenance and the mitotic cell cycle in the distal germline [3]. Once a GSC moves away from the DTC niche, it enters the meiotic cell cycle and eventually differentiates into sperm or oocytes (Figure 1A). In addition, C. elegans is an attractive model organism due to the ease of generating mutant strains, genetic manipulation, phenotype analysis, microscopy, and imaging. Therefore, the C. elegans germline has been widely used as a model organism in various biomedical fields, including research on tumorigenesis.

1.2. Three Distinct Mechanisms of C. elegans Germline Tumorigenesis

Germline tumors observed in mutant C. elegans individuals can originate from different sources, depending on the mechanism of tumorigenesis. In the context of C. elegans, the term “tumorous” is used to define germlines that exhibit three distinctive features (Figure 1B): (1) a vast excess of mitotic cells through ectopic proliferation, (2) minimal or no germ cell differentiation due to meiotic entry failure, and (3) the generation of mitotic germ cells through dedifferentiation. This report outlines three distinct mechanisms of tumorigenesis.

2. GLP-1/Notch Activation-Mediated Tumorigenesis: Ectopic Proliferation

2.1. Notch Signaling

In most multicellular organisms, the Notch signaling pathway is highly conserved and controls various cellular processes, including proliferation, differentiation, cell fate specification, and other cellular responses (Artavanis-Tsakonas et al., 1999). Notch ligands (DSL: Delta/Serrate/LAG-2) are expressed on the membrane of donor cells adjacent to receiving cells expressing Notch receptors (Figure 2A). Upon interaction between the Notch receptor and a ligand, an ADAM-family metalloprotease cleaves the exterior of the Notch receptor, followed by g-secretase cleaving the inner portion of the Notch receptor within the cell membrane. This Notch intracellular domain (NICD) relocates to the nucleus, where it forms a tertiary complex with CSL (CBF1/Suppressor of Hairless/LAG-1) transcription factors and mastermind-like protein (MAML-1), leading to the activation of Notch target genes. Notably, aberrant Notch signaling can lead to uncontrolled cell growth, metastasis, and resistance to apoptosis [4]. Therefore, understanding the precise mechanism governing context-dependent outcomes of Notch signaling is crucial.

2.2. C. elegans Notch Signaling and Its Core Regulators

The Notch signaling pathway and its core regulators are highly conserved in C. elegans (Figure 2B). Two distinct Notch receptors exist in this organism: GLP-1 (GermLine Proliferation-1) and LIN-12 (cell LINeage-12). GLP-1 is primarily found in germ cells and plays a critical role in the maintenance and mitotic division of GSCs [3]. Conversely, LIN-12 is predominantly present in somatic cells and is essential for determining the fate of vulva cells during early larval development [5]. The activation of GLP-1 signaling requires two Notch ligands: LAG-2 and APX-1 [6,7]. LAG-2 is mainly found in the DTC, which acts as a niche for GSCs. When LAG-2 interacts with GLP-1, a cascade of cleavage events is initiated, leading to the release of the NICD [8]. Subsequently, GLP-1(NICD) forms a tertiary complex with LAG-1 and LAG-3, activating transcription for its target genes [8]. Two target genes, lateral signaling target (lst-1) and synthetic GLP (sygl-1), have been extensively studied [9]. These genes function redundantly in the maintenance and mitotic division of GSCs [9]. While a single mutation for either sygl-1 or lst-1 can sustain GSCs, double mutations show no GSC phenotype, similar to glp-1(null) mutants [9]. Notably, overexpression of either sygl-1 or lst-1 induces the formation of germline tumors, resembling the phenotype observed in glp-1 gain-of-function (gf) mutants [10]. These findings highlight the crucial role of two GLP-1 target genes in the maintenance and mitotic division of GSCs.

2.3. GLP-1 Mutant Alleles

The primary distinction between the two groups of mutants lies in their germline phenotype. Loss-of-function mutants significantly reduce GSCs, while gain-of-function mutations form germline tumors. These glp-1 mutants have served as valuable tools to identify genes associated with GLP-1 signaling. The representative mutant alleles are listed in Table 1.

2.4. Positive or Negative Regulators of GLP-1/Notch Signaling

While most glp-1(ar202) and glp-1(bn18) mutants are fertility at 15°C or 20°C, the majority of glp-1(ar202) gain-of-function mutants develop germline tumors upon shifting to 25°C [14], whereas most glp-1(bn18) loss-of-function mutants exhibit defects in germline proliferation at 25°C, resulting in no germ cells [11]. These intriguing phenotypes provide an opportunity to identify genes that positively or negatively regulate GLP-1/Notch signaling (Figure 2C).
  • CYE-1 and CDK-2: Fox et al. found that germline CYE-1 and CDK-2 are required for GLP-1/Notch-mediated germ cell proliferation. RNAi-mediated depletion of CYE-1 or CDK-2 significantly suppressed germ cell proliferative fate in glp-1(bn18) mutants even at 20°C [15]. Additional genetic analysis suggests that CYE-1 and CDK-2 act independently of GLP-1/Notch signaling to promote proliferative fate [15].
  • Subunits of the DNA polymerase alpha-primase complex: Yoon et al. found that DIV-1 (regulatory subunit) is indispensable for GLP-1/Notch-mediated germ cell proliferation during early larval development, whereas POLA-1 (catalytic subunit) and two primase subunits, PRI-1 and PRI-2, play a crucial role in GLP-1/Notch-mediated maintenance of proliferative cell fate during adulthood [16]. Robinson-Thiewes et al. also identified POLE-1 (the catalytic subunit of DNA polymerase e) as a regulator of germ cell proliferation [17].
  • Chaperone HSP90: Lissemore et al. performed a genetic screening to identify genes that promote GLP-1/Notch signaling and found that HSP-90, a molecular chaperone, plays an essential role in stem cell maintenance [18]. It was a novel finding demonstrating the essential role of HSP90 in Notch signaling in development.
  • Ribosomal Protein S6 kinase (S6K): Roy et al. identified RSKS-1/S6K as a positive regulator of GLP-1/Notch signaling-mediated germline proliferation [19]. Additional screening also found that Hedgehog-related ligands may share functional relationships with GLP-1/Notch and RSKS-1/S6K in maintaining GSCs [19].
  • Bro1-domain protein: Liu and Maine identified the ego-2 (enhancer of glp-1) gene as a positive regulator of germline proliferation that interacts genetically with the GLP-1/Notch signaling pathway [20]. Notably, ego-2 also promotes LIN-12/Notch signaling in somatic tissues [20]. They found that the EGO-1 protein contains a Bro1 domain, which localizes to specific endosomal compartments in other systems. Thus, they suggest that EGO-2 may promote GLP-1/Notch signaling through endocytic process function [20].
  • Derlin family proteins: Singh et al. demonstrated that reduced CUP-2 and DER-2 function suppresses GLP-1/Notch-mediated germline tumorigenesis [21]. CUP-2 and DER-2 are Derlin family proteins that function in endoplasmic reticulum-associated degradation (ERAD). Therefore, they suggest that Derlin activity may be associated with GLP-1/Notch-mediated tumorigenesis [21].
  • U/T level: Chi et al. demonstrated that GLP-1 expression in the distal gonad region is repressed by low Uridine/Thymidine (U/T) levels [22]. C. elegans CDD-1/-2 Cytidine Deaminases are involved in uridine biosynthesis. Notably, worms lacking both CDD-1 and CDD-2 exhibited germline proliferation defects, whose phenotype was rescued by Uridine supplementation [22].
  • TRIM-NHL protein: Brenner et al. identified nhl-2 as an inhibitor of glp-1(ar202)-mediated tumorigenesis [23]. NHL-2, a conserved TRIM-NHL protein family member, suppresses germ cell proliferation by inhibiting PUF-3 and PUF-11. They also found that CGH-1 RNA helicase and ALG-5 work with NHL-2 to inhibit glp-1(ar202)-mediated tumorigenesis.
  • E3 Ubiquitin ligase: Gutnik et al. reported that the splicing factor PRP-19 (a candidate E3 ubiquitin ligase) inhibits the nuclear accumulation of the GLP-1/Notch intracellular domain [24].
  • PUF RNA-binding protein: PUF-8 is a conserved PUF RNA-binding protein that inhibits the translation of target mRNAs. In C. elegans germline, PUF-8 is involved in decisions regarding proliferation/differentiation, differentiation/dedifferentiation, and sperm/oocyte fates, depending on the genetic context [25]. Racher and Hansen demonstrated that PUF-8 inhibits glp-1(ar202)-mediated tumorigenesis in the C. elegans germline [26]. Other PUF proteins (FBF-1/2 and PUF-3/11) also play a critical role in GSC maintenance [27].
  • Syndecan: Gopal et al. identified SDN-1 (a syndecan transmembrane proteoglycan) as a positive regulator of GLP-1/Notch signaling. SDN-1 promotes GLP-1 expression and mitotic germ cell fate by controlling a somatic TRP calcium channel. The TRP enhances glp-1 expression by governing the calcium-dependent binding of an AP-2 transcription factor (APTF-2) [28].

3. GLD-1 Loss-Mediated Tumorigenesis: Meiotic Entry Failure

3.1. STAR Family of RNA-Binding Proteins

The signal transduction activator of RNA metabolism (STAR) family of KH domain RNA-binding proteins is a highly conserved group of proteins among eukaryotes [29]. The STAR protein family operates at the post-transcriptional level, being involved in the stability, alternative splicing, and translational efficiency of their mRNA targets, thus influencing downstream gene expression [30]. Although STAR proteins are highly conserved, they exhibit variability in specific regions and specificity to certain RNA sequences in each model organism [31]. Moreover, RNA-recognition mechanisms by STAR proteins are yet to be explicitly defined for many models. Many STAR proteins have been identified with diverse roles across animal models [32]. For example, the held-out wing (HOW) gene in Drosophila is involved in embryonic cardiac development, and the alternative splicing defective-2 (ASD-2) gene in C. elegans is involved in the developmental control of alternative splicing [33,34]. STAR proteins also play an essential role in the development of vertebrate models. Most notably, mutations and loss of function in the quaking gene (QK1) in mice models have been shown to cause deficiencies in adult mice astrocyte maturation [35]. Furthermore, STAR proteins have been implicated in human disease [35,36]. More research is needed to elucidate the full pleiotropic effects and mechanisms of STAR proteins and their role in developmental maturation.

3.2. C. elegans gld-1 and Its Partners

C. elegans STAR RNA-binding protein GLD-1 (GermLine development Defective) plays multiple critical roles in C. elegans germline development. One well-known function is inhibiting germ cell proliferation [37,38]. Germ cells lacking GLD-1 enter the meiotic cell cycle and revert to the mitotic cell cycle, leading to the formation of germline tumors (Figure 1B). GLD-1 is predominantly expressed in the cytoplasm of premeiotic and pachytene cells in the C. elegans germline [38]. GLD-1 exerts its regulatory functions by binding to conserved sequence motifs (AGAAGC, CUACUAAC, or GAACGA) in the 5’ and 3’ UTRs of its mRNA target [39,40] (Figure 3A). Thereby modulating their stability and/or translation [41]. Several GLD-1 target mRNAs have been identified through biochemical and functional analyses, including rme-2, gna-2 [42], lin-45, tra-2, glp-1 [43], pos-1, pal-1 [44], cye-1, cep-1 [45], mes-3 [46], and four puf genes (puf-5, 6, 7, 8 and 10) [40,47]. RNA-IP/Chip analysis has further identified putative GLD-1 targets, primarily involved in reproduction, embryogenesis, cell division, and cell cycle [41]. GLD-1 and its partner NOS-3 (a member of the Nanos family of zinc finger proteins) act as a translational repressor to promote meiotic prophase progression in the C. elegans germline [48,49]. Moreover, the GLD-1/NOS-3 complex works with the GLD-2/GLD-3 complex, which promotes germline differentiation [48,49]. Thus, the GLD-1/NOS-3 and GLD-2/GLD-3 complexes are essential for germline differentiation, particularly through meiotic entry (Figure 3B).
3.3. gld-1 Mutant Alleles
The gld-1 gene plays a crucial role in meiotic progression and oocyte development. The formation of germline tumors in gld-1(q485) loss-of-function mutants is dependent on the sexual fate of the germline [50]. In gld-1(q485) loss-of-function mutant germline, germ cells exit the meiotic prophase but return to the mitotic cell cycle in the oogenic germline, while these germ cells can differentiate into sperm in the spermatogenic germline [50]. The representative mutant alleles are listed in Table 2.

3.4. Positive or Negative Regulators of GLD-1

The Regulators of GLD-1 Are Depicted in Figure 3B.
  • GLD-2 poly(A) polymerase (PAP): GLD-2 is a cytoplasmic poly(A) polymerase [52]. It plays a critical role in meiotic entry and progression [53,54]. Thus, no functional gametes are produced in the absence of GLD-2 [53]. Notably, the gld-1 mRNA is a direct target of GLD-2 [55]. GLD-2 poly(A) polymerase promotes meiotic entry, at least in part, by activating GLD-1 expression. Consequently, GLD-2 loss enhances the formation of germline tumors in gld-1 loss-of-function mutant worms [53].
  • FBF/PUF RNA-binding protein: C. elegans FBF/PUF proteins play a crucial role in maintaining GSCs by regulating the expression of various target mRNAs, including the gld-1 mRNA [56]. Since GLD-1 is essential for inhibiting proliferation and maintaining the differentiation state of germ cells, FBF/PUF repression of gld-1 mRNAs is critical for GSC maintenance. In addition, C. elegans PUF-8 proteins negatively inhibit the expression of gld-1 mRNAs by inhibiting gld-2 mRNAs indirectly [57].
  • CYE-1/CDK2: CYE-1/CDK2 influences the mitosis/meiosis balance through GLD-1 [15,58]. Specifically, GLD-1 has CDK2 phosphorylation sites and appears to be a direct substrate of CYE-1/CDK2. Functional analysis showed that CYE-1/CDK2 works with FBF-1 to maintain GSCs by inhibiting GLD-1. Notably, cye-1 mRNA is also a repressing target of GLD-1 [59]. Therefore, GLD-1 and CYE-1/CDK2 inhibit each other for the mitosis/meiosis balance.
  • Pre-mRNA Splicing Factor (PRP-17): Kerins et al. reported that PRP-17 and other C. elegans splicing factor orthologs function to promote meiotic entry by positively regulating the splicing of mRNAs of genes in the GLD-1 pathway [60].

4. PUF-8 Loss-Mediated Tumorigenesis: Spermatogenic Dedifferentiation

4.1. PUF RNA-Binding Proteins

Pumilio and FBF (PUF) proteins are highly conserved stem cell regulators that maintain GSCs in worms and flies and have also been identified in vertebrate stem cells [25,61,62,63,64,65]. These proteins control mRNA translation or stability by binding to regulatory elements in the 3’ UTR of their target mRNAs (Figure 4A). Specifically, they repress the expression of target mRNAs by recruiting the Ccr4-Pop2-NOT deadenylase complex to trim the poly(A) tails [66] and/or by interacting with Argonaute proteins to stall translation elongation [67] (Figure 4A). Notably, many PUF-repressing target mRNAs repressed by PUF proteins are shared among worms, flies, and humans, including components of cell signaling, cell cycle regulation, and development [68]. One of the conserved target mRNAs is an ERK MAPK mRNA [64,69]. PUF proteins inhibit the expression of MAPK mRNAs in both C. elegans and human embryonic stem cells [64]. In humans, two PUF proteins, PUM1 and PUM2, have distinct roles in the self-renewal and differentiation of mesenchymal stem cells (MSCs) [65]. PUM1 is critical for MSC self-renewal and proliferation, while PUM2 represses the osteogenic differentiation of MSCs by inhibiting JAK2 and RUNX2 mRNAs [65]. Since cancer stem cells have similar characteristics, several studies have highlighted the novel function of PUM1 in cancer stem cells and cancer progression [70,71,72]. For example, Pumilio proteins promote colorectal cancer progression by inhibiting the expression of p21 mRNA [73]. Therefore, PUF proteins play critical roles in regulating various cellular processes and tumorigenesis at a post-transcriptional level.

4.2. C. elegans PUF-8

C. elegans possesses 11 PUF genes [74] (Figure 4B). Among them, PUF-8 is predominantly expressed in the distal germline and plays a key role in regulating various cellular processes, depending on the genetic context in the C. elegans germline [25]. For example, PUF-8 and MEX-3 are critical for GSC proliferation [75], whereas PUF-8 and LIP-1 promote GSC differentiation and oogenic fate by inhibiting the MPK-1/ERK signaling pathway [76]. PUF-8 also works with FBF-1 to promote oogenic fate and inhibit spermatogenic fate [77]. The PUF-8 protein recognizes a regulatory element [UGUAnA(U/A)A] on the 3’UTR of target mRNAs [57]. In silico analysis has identified approximately 800 genes harboring at least one PBE in their 3’UTRs. mRNA-seq analysis revealed that 4638 genes were upregulated and 4855 genes were downregulated in the puf-8(ok302) null mutant [78]. Notably, about 500 genes contained the PBE sequence in both groups of genes [78]. To date, biochemical analyses, such as yeast-three hybrid, gel shift, or RT-PCR, have verified several targets of PUF-8 regulation, including gld-2 [57], ced-3 [79], let-60 [80], pqm-1 [78], pha-4 [78], blmp-1 [78], vhp-1 [78], and hih-30 [78]. Recent reports also indicate that PUF-8 proteins regulate C. elegans lifespan through pathways involving MFF mitochondria fission factor and pqm-1-related lipid storage [78].
4.3. puf-8 Mutant Alleles
puf-8 loss-of-function mutants exhibit fertility at permissive temperature (20°C) but develop partially germline tumors via dedifferentiation at restrictive temperature (25°C) [81,82]. Specifically, abnormal spermatocytes in puf-8 loss-of-function or null mutant germlines return to the mitotic cell cycle via dedifferentiation mechanisms [81,82]. Additionally, as noted in section 2.4., puf-8 loss-of-function or null mutations can induce germline tumors in glp-1(ar202) gain-of-function mutant germlines through non-dedifferentiation-mediated mechanisms. The representative mutant alleles are listed in Table 3.

4.4. Positive or Negative Regulators of PUF-8

The Regulators of PUF-8 Are Depicted in Figure 4B.
  • LIP-1 dual-specificity phosphatase: puf-8(q725) mutants are self-fertile at 20°C. However, at 25°C, ~10% of 1-day adult puf-8(q725) mutants develop germline tumors [82]. Notably, the germline tumor phenotype of puf-8(q725) mutants is dramatically enhanced by the additional loss of LIP-1 [82]. This finding indicates that PUF-8 works with LIP-1 to inhibit dedifferentiation-mediated tumorigenesis by promoting the meiotic division of spermatocytes in the C. elegans germline [82].
  • MPK-1/ERK MAPK: The Ras-ERK/MAP kinase signaling pathway governs many cellular processes, such as proliferation, differentiation, cell fate decision, and survival in most eukaryotes [69]. Components of the C. elegans Ras-ERK pathway, such as LET-60/Ras and MPK-1/ERK, are highly conserved and essential for germline development, including meiotic progression, sperm fate specification, and oocyte maturation [83]. Notably, the reduction of Ras-ERK MAPK signaling, either by mutation or chemical inhibition, blocked the initiation of dedifferentiation in puf-8(q725); lip-1(zh15) mutant germlines [82,84]. These findings indicate that MPK-1/ERK signaling pathways are critical for puf-8(q725) dedifferentiation-mediated tumorigenesis.
  • GLD-1 and GLD-2: Park et al. recently reported that PUF-8 binds specifically to a PBE in gld-2 3’UTR and represses a GFP reporter gene carrying gld-2 3’UTR in the C. elegans mitotic germ cells [57]. Notably, the removal of both gld-2 and its activating target, gld-1, significantly increased puf-8(q725) dedifferentiation-mediated germline tumors [57]. These results indicate that GLD-1 and GLD-2 may inhibit dedifferentiation-mediated germline tumors in puf-8(q725) mutant germline by promoting germ cell differentiation.

5. Conclusions

Tumorigenesis can occur through various mechanisms, such as genetic mutations, epigenetic alterations, chromosomal abnormalities, immune system dysfunction, changes in the tumor microenvironments, and metabolic changes. In this report, we describe three specific tumor models: tumorigenesis mediated by (1) aberrant GLP-1/Notch activation, (2) gld-1 loss-of-function-mediated differentiation failure, and (3) puf-8 loss-of-function-mediated dedifferentiation (Figure 1B). Notably, each model requires the mutation of distinct genes (glp-1, gld-1, and puf-8) and operates through different underlying mechanisms. However, regulators within each tumor model exhibit shared features. For example, a puf-8(q725) mutation initially triggers dedifferentiation-mediated tumorigenesis, further enhanced by the additional mutation of lip-1. Interestingly, the same puf-8(q725) mutation also induces glp-1(ar202)-mediated tumorigenesis through a different mechanism. Similarly, a gld-1(q485) mutation initially leads to the formation of germline tumors due to differentiation failure, but this mutation also enhances puf-8(q725) dedifferentiation-mediated tumorigenesis. We also found that GLP-1/Notch signaling is involved in puf-8(q725) dedifferentiation-mediated tumorigenesis (Jones et al., unpublished results). These observations hypothesize that there may be shared internal regulatory networks that maintain the original tumorigenesis pathway. This idea also suggests specific therapies targeting both the origin of tumorigenesis and the internal regulatory networks. Consequently, the three distinct tumor models in C. elegans serve as valuable tools for identifying genes and developing unique therapeutics targeted to specific tumor pathways. This conceptual framework also provides insights into more complex tumor models in other organisms, including humans.

Author Contributions

Conceptualization, M.J. and M.H.L.; writing— original draft preparation, M.J., and M.H.L.; writing—review and editing, M.J., M.N., A.M.T., J.L., and M.H.L.; visualization, J.L., and M.H.L.; supervision, M.H.L.; funding acquisition, M.H.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Lung Cancer Initiative (217045), NIH (AG060373-01), and NSF (IOS 2132286) to MHL.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are available for research purposes upon reasonable request to the corresponding author.

Acknowledgments

We thank the members of the Lee laboratory for helpful advice and discussion during the work.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57–70. [Google Scholar] [CrossRef] [PubMed]
  2. Kirienko, N.V.; Mani, K.; Fay, D.S. Cancer models in Caenorhabditis elegans. Developmental dynamics: an official publication of the American Association of Anatomists 2010, 239, 1413–1448. [Google Scholar] [CrossRef] [PubMed]
  3. Kimble, J.; Crittenden, S.L. Controls of germline stem cells, entry into meiosis, and the sperm/oocyte decision in Caenorhabditis elegans. Annual review of cell and developmental biology 2007, 23, 405–433. [Google Scholar] [CrossRef] [PubMed]
  4. Zhou, B.; Lin, W.; Long, Y.; Yang, Y.; Zhang, H.; Wu, K.; Chu, Q. Notch signaling pathway: architecture, disease, and therapeutics. Signal transduction and targeted therapy 2022, 7, 95. [Google Scholar] [CrossRef] [PubMed]
  5. Greenwald, I. LIN-12/Notch signaling in C. elegans. WormBook: the online review of C. elegans biology, 2005; 1–16. [Google Scholar] [CrossRef]
  6. Henderson, S.T.; Gao, D.; Lambie, E.J.; Kimble, J. lag-2 may encode a signaling ligand for the GLP-1 and LIN-12 receptors of C. elegans. Development 1994, 120, 2913–2924. [Google Scholar] [CrossRef]
  7. Tax, F.E.; Thomas, J.H. Cell-cell interactions. Receiving signals in the nematode embryo. Current biology: CB 1994, 4, 914–916. [Google Scholar] [CrossRef] [PubMed]
  8. Kobet, R.A.; Pan, X.; Zhang, B.; Pak, S.C.; Asch, A.S.; Lee, M.H. Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification. Biomolecules & therapeutics 2014, 22, 371–383. [Google Scholar] [CrossRef] [PubMed]
  9. Kershner, A.M.; Shin, H.; Hansen, T.J.; Kimble, J. Discovery of two GLP-1/Notch target genes that account for the role of GLP-1/Notch signaling in stem cell maintenance. Proceedings of the National Academy of Sciences of the United States of America 2014, 111, 3739–3744. [Google Scholar] [CrossRef] [PubMed]
  10. Shin, H.; Haupt, K.A.; Kershner, A.M.; Kroll-Conner, P.; Wickens, M.; Kimble, J. SYGL-1 and LST-1 link niche signaling to PUF RNA repression for stem cell maintenance in Caenorhabditis elegans. PLoS genetics 2017, 13, e1007121. [Google Scholar] [CrossRef]
  11. Kodoyianni, V.; Maine, E.M.; Kimble, J. Molecular basis of loss-of-function mutations in the glp-1 gene of Caenorhabditis elegans. Molecular biology of the cell 1992, 3, 1199–1213. [Google Scholar] [CrossRef]
  12. Austin, J.; Kimble, J. glp-1 is required in the germ line for regulation of the decision between mitosis and meiosis in C. elegans. Cell 1987, 51, 589–599. [Google Scholar] [CrossRef]
  13. Berry, L.W.; Westlund, B.; Schedl, T. Germ-line tumor formation caused by activation of glp-1, a Caenorhabditis elegans member of the Notch family of receptors. Development 1997, 124, 925–936. [Google Scholar] [CrossRef] [PubMed]
  14. Pepper, A.S.; Killian, D.J.; Hubbard, E.J. Genetic analysis of Caenorhabditis elegans glp-1 mutants suggests receptor interaction or competition. Genetics 2003, 163, 115–132. [Google Scholar] [CrossRef] [PubMed]
  15. Fox, P.M.; Vought, V.E.; Hanazawa, M.; Lee, M.H.; Maine, E.M.; Schedl, T. Cyclin E and CDK-2 regulate proliferative cell fate and cell cycle progression in the C. elegans germline. Development 2011, 138, 2223–2234. [Google Scholar] [CrossRef] [PubMed]
  16. Yoon, D.S.; Cha, D.S.; Alfhili, M.A.; Keiper, B.D.; Lee, M.H. Subunits of the DNA polymerase alpha-primase complex promote Notch-mediated proliferation with discrete and shared functions in C. elegans germline. The FEBS journal 2018. [Google Scholar] [CrossRef] [PubMed]
  17. Robinson-Thiewes, S.; Kershner, A.M.; Shin, H.; Haupt, K.A.; Kroll-Connor, P.; Kimble, J. A sensitized genetic screen to identify regulators of Caenorhabditis elegans germline stem cells. G3 (Bethesda) 2022, 12. [Google Scholar] [CrossRef] [PubMed]
  18. Greenblatt, E.; Casper, R.F. Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome. American journal of obstetrics and gynecology 1987, 156, 279–285. [Google Scholar] [CrossRef] [PubMed]
  19. Roy, D.; Kahler, D.J.; Yun, C.; Hubbard, E.J.A. Functional Interactions Between rsks-1/S6K, glp-1/Notch, and Regulators of Caenorhabditis elegans Fertility and Germline Stem Cell Maintenance. G3 (Bethesda) 2018, 8, 3293–3309. [Google Scholar] [CrossRef] [PubMed]
  20. Liu, Y.; Maine, E.M. The Bro1-domain protein, EGO-2, promotes Notch signaling in Caenorhabditis elegans. Genetics 2007, 176, 2265–2277. [Google Scholar] [CrossRef]
  21. Singh, R.; Smit, R.B.; Wang, X.; Wang, C.; Racher, H.; Hansen, D. Reduction of Derlin activity suppresses Notch-dependent tumours in the C. elegans germ line. PLoS genetics 2021, 17, e1009687. [Google Scholar] [CrossRef]
  22. Chi, C.; Ronai, D.; Than, M.T.; Walker, C.J.; Sewell, A.K.; Han, M. Nucleotide levels regulate germline proliferation through modulating GLP-1/Notch signaling in C. elegans. Genes & development 2016, 30, 307–320. [Google Scholar] [CrossRef] [PubMed]
  23. Brenner, J.L.; Jyo, E.M.; Mohammad, A.; Fox, P.; Jones, V.; Mardis, E.; Schedl, T.; Maine, E.M. TRIM-NHL protein, NHL-2, modulates cell fate choices in the C. elegans germ line. Developmental biology 2022, 491, 43–55. [Google Scholar] [CrossRef] [PubMed]
  24. Gutnik, S.; Thomas, Y.; Guo, Y.; Stoecklin, J.; Neagu, A.; Pintard, L.; Merlet, J.; Ciosk, R. PRP-19, a conserved pre-mRNA processing factor and E3 ubiquitin ligase, inhibits the nuclear accumulation of GLP-1/Notch intracellular domain. Biology open 2018, 7. [Google Scholar] [CrossRef] [PubMed]
  25. Datla, U.S.; Scovill, N.C.; Brokamp, A.J.; Kim, E.; Asch, A.S.; Lee, M.H. Role of PUF-8/PUF protein in stem cell control, sperm-oocyte decision and cell fate reprogramming. Journal of cellular physiology 2014, 229, 1306–1311. [Google Scholar] [CrossRef]
  26. Racher, H.; Hansen, D. PUF-8, a Pumilio homolog, inhibits the proliferative fate in the Caenorhabditis elegans germline. G3 (Bethesda) 2012, 2, 1197–1205. [Google Scholar] [CrossRef] [PubMed]
  27. Haupt, K.A.; Law, K.T.; Enright, A.L.; Kanzler, C.R.; Shin, H.; Wickens, M.; Kimble, J. A PUF Hub Drives Self-Renewal in Caenorhabditis elegans Germline Stem Cells. Genetics 2020, 214, 147–161. [Google Scholar] [CrossRef] [PubMed]
  28. Gopal, S.; Amran, A.; Elton, A.; Ng, L.; Pocock, R. A somatic proteoglycan controls Notch-directed germ cell fate. Nature communications 2021, 12, 6708. [Google Scholar] [CrossRef]
  29. Hernandez, M.L.; Martinez, M.J.; Lopez de Heredia, M.; Ochoa, B. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA:cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes. Biochimica et biophysica acta 1997, 1349, 233–241. [Google Scholar] [CrossRef] [PubMed]
  30. Keene, J.D.; Lager, P.J. Post-transcriptional operons and regulons co-ordinating gene expression. Chromosome research: an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology 2005, 13, 327–337. [Google Scholar] [CrossRef]
  31. Ryder, S.P.; Massi, F. Insights into the structural basis of RNA recognition by STAR domain proteins. Advances in experimental medicine and biology 2010, 693, 37–53. [Google Scholar] [CrossRef]
  32. Artzt, K.; Wu, J.I. STAR trek: An introduction to STAR family proteins and review of quaking (QKI). Advances in experimental medicine and biology 2010, 693, 1–24. [Google Scholar] [PubMed]
  33. Zaffran, S.; Astier, M.; Gratecos, D.; Semeriva, M. The held out wings (how) Drosophila gene encodes a putative RNA-binding protein involved in the control of muscular and cardiac activity. Development 1997, 124, 2087–2098. [Google Scholar] [CrossRef] [PubMed]
  34. Ohno, G.; Hagiwara, M.; Kuroyanagi, H. STAR family RNA-binding protein ASD-2 regulates developmental switching of mutually exclusive alternative splicing in vivo. Genes & development 2008, 22, 360–374. [Google Scholar] [CrossRef] [PubMed]
  35. Sakers, K.; Liu, Y.; Llaci, L.; Lee, S.M.; Vasek, M.J.; Rieger, M.A.; Brophy, S.; Tycksen, E.; Lewis, R.; Maloney, S.E.; et al. Loss of Quaking RNA binding protein disrupts the expression of genes associated with astrocyte maturation in mouse brain. Nature communications 2021, 12, 1537. [Google Scholar] [CrossRef] [PubMed]
  36. Haroutunian, V.; Katsel, P.; Dracheva, S.; Davis, K.L. The human homolog of the QKI gene affected in the severe dysmyelination “quaking” mouse phenotype: downregulated in multiple brain regions in schizophrenia. The American journal of psychiatry 2006, 163, 1834–1837. [Google Scholar] [CrossRef]
  37. Francis, R.; Barton, M.K.; Kimble, J.; Schedl, T. gld-1, a tumor suppressor gene required for oocyte development in Caenorhabditis elegans. Genetics 1995, 139, 579–606. [Google Scholar] [CrossRef] [PubMed]
  38. Jones, A.R.; Francis, R.; Schedl, T. GLD-1, a cytoplasmic protein essential for oocyte differentiation, shows stage- and sex-specific expression during Caenorhabditis elegans germline development. Developmental biology 1996, 180, 165–183. [Google Scholar] [CrossRef]
  39. Carmel, A.B.; Wu, J.; Lehmann-Blount, K.A.; Williamson, J.R. High-affinity consensus binding of target RNAs by the STAR/GSG proteins GLD-1, STAR-2 and Quaking. BMC molecular biology 2010, 11, 48. [Google Scholar] [CrossRef] [PubMed]
  40. Ryder, S.P.; Frater, L.A.; Abramovitz, D.L.; Goodwin, E.B.; Williamson, J.R. RNA target specificity of the STAR/GSG domain post-transcriptional regulatory protein GLD-1. Nature structural & molecular biology 2004, 11, 20–28. [Google Scholar] [CrossRef]
  41. Doh, J.H.; Jung, Y.; Reinke, V.; Lee, M.H. C. elegans RNA-binding protein GLD-1 recognizes its multiple targets using sequence, context, and structural information to repress translation. Worm 2013, 2, e26548. [Google Scholar] [CrossRef]
  42. Lee, M.H.; Schedl, T. Translation repression by GLD-1 protects its mRNA targets from nonsense-mediated mRNA decay in C. elegans. Genes & development 2004, 18, 1047–1059. [Google Scholar] [CrossRef] [PubMed]
  43. Farley, B.M.; Ryder, S.P. POS-1 and GLD-1 repress glp-1 translation through a conserved binding-site cluster. Molecular biology of the cell 2012, 23, 4473–4483. [Google Scholar] [CrossRef] [PubMed]
  44. Mootz, D.; Ho, D.M.; Hunter, C.P. The STAR/Maxi-KH domain protein GLD-1 mediates a developmental switch in the translational control of C. elegans PAL-1. Development 2004, 131, 3263–3272. [Google Scholar] [CrossRef] [PubMed]
  45. Schumacher, B.; Hanazawa, M.; Lee, M.H.; Nayak, S.; Volkmann, K.; Hofmann, E.R.; Hengartner, M.; Schedl, T.; Gartner, A. Translational repression of C. elegans p53 by GLD-1 regulates DNA damage-induced apoptosis. Cell 2005, 120, 357–368. [Google Scholar] [CrossRef] [PubMed]
  46. Xu, L.; Paulsen, J.; Yoo, Y.; Goodwin, E.B.; Strome, S. Caenorhabditis elegans MES-3 is a target of GLD-1 and functions epigenetically in germline development. Genetics 2001, 159, 1007–1017. [Google Scholar] [CrossRef] [PubMed]
  47. Scheckel, C.; Gaidatzis, D.; Wright, J.E.; Ciosk, R. Genome-wide analysis of GLD-1-mediated mRNA regulation suggests a role in mRNA storage. PLoS genetics 2012, 8, e1002742. [Google Scholar] [CrossRef] [PubMed]
  48. Crittenden, S.L.; Eckmann, C.R.; Wang, L.; Bernstein, D.S.; Wickens, M.; Kimble, J. Regulation of the mitosis/meiosis decision in the Caenorhabditis elegans germline. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2003, 358, 1359–1362. [Google Scholar] [CrossRef] [PubMed]
  49. Hansen, D.; Wilson-Berry, L.; Dang, T.; Schedl, T. Control of the proliferation versus meiotic development decision in the C. elegans germline through regulation of GLD-1 protein accumulation. Development 2004, 131, 93–104. [Google Scholar] [CrossRef] [PubMed]
  50. Francis, R.; Maine, E.; Schedl, T. Analysis of the multiple roles of gld-1 in germline development: interactions with the sex determination cascade and the glp-1 signaling pathway. Genetics 1995, 139, 607–630. [Google Scholar] [CrossRef]
  51. Rutkowski, R.; Dickinson, R.; Stewart, G.; Craig, A.; Schimpl, M.; Keyse, S.M.; Gartner, A. Regulation of Caenorhabditis elegans p53/CEP-1-dependent germ cell apoptosis by Ras/MAPK signaling. PLoS genetics 2011, 7, e1002238. [Google Scholar] [CrossRef]
  52. Wang, L.; Eckmann, C.R.; Kadyk, L.C.; Wickens, M.; Kimble, J. A regulatory cytoplasmic poly(A) polymerase in Caenorhabditis elegans. Nature 2002, 419, 312–316. [Google Scholar] [CrossRef] [PubMed]
  53. Kadyk, L.C.; Kimble, J. Genetic regulation of entry into meiosis in Caenorhabditis elegans. Development 1998, 125, 1803–1813. [Google Scholar] [CrossRef] [PubMed]
  54. Eckmann, C.R.; Crittenden, S.L.; Suh, N.; Kimble, J. GLD-3 and control of the mitosis/meiosis decision in the germline of Caenorhabditis elegans. Genetics 2004, 168, 147–160. [Google Scholar] [CrossRef] [PubMed]
  55. Suh, N.; Jedamzik, B.; Eckmann, C.R.; Wickens, M.; Kimble, J. The GLD-2 poly(A) polymerase activates gld-1 mRNA in the Caenorhabditis elegans germ line. Proceedings of the National Academy of Sciences of the United States of America 2006, 103, 15108–15112. [Google Scholar] [CrossRef] [PubMed]
  56. Crittenden, S.L.; Bernstein, D.S.; Bachorik, J.L.; Thompson, B.E.; Gallegos, M.; Petcherski, A.G.; Moulder, G.; Barstead, R.; Wickens, M.; Kimble, J. A conserved RNA-binding protein controls germline stem cells in Caenorhabditis elegans. Nature 2002, 417, 660–663. [Google Scholar] [CrossRef] [PubMed]
  57. Park, Y.; O’Rourke, S.; Taki, F.A.; Alfhili, M.A.; Lee, M.H. Dose-Dependent Effects of GLD-2 and GLD-1 on Germline Differentiation and Dedifferentiation in the Absence of PUF-8. Frontiers in cell and developmental biology 2020, 8, 5. [Google Scholar] [CrossRef]
  58. Jeong, J.; Verheyden, J.M.; Kimble, J. Cyclin E and Cdk2 control GLD-1, the mitosis/meiosis decision, and germline stem cells in Caenorhabditis elegans. PLoS genetics 2011, 7, e1001348. [Google Scholar] [CrossRef]
  59. Biedermann, B.; Wright, J.; Senften, M.; Kalchhauser, I.; Sarathy, G.; Lee, M.H.; Ciosk, R. Translational repression of cyclin E prevents precocious mitosis and embryonic gene activation during C. elegans meiosis. Developmental cell 2009, 17, 355–364. [Google Scholar] [CrossRef]
  60. Kerins, J.A.; Hanazawa, M.; Dorsett, M.; Schedl, T. PRP-17 and the pre-mRNA splicing pathway are preferentially required for the proliferation versus meiotic development decision and germline sex determination in Caenorhabditis elegans. Developmental dynamics: an official publication of the American Association of Anatomists 2010, 239, 1555–1572. [Google Scholar] [CrossRef]
  61. Wang, X.; Voronina, E. Diverse Roles of PUF Proteins in Germline Stem and Progenitor Cell Development in C. elegans. Frontiers in cell and developmental biology 2020, 8, 29. [Google Scholar] [CrossRef]
  62. Nishanth, M.J.; Simon, B. Functions, mechanisms and regulation of Pumilio/Puf family RNA binding proteins: a comprehensive review. Molecular biology reports 2020, 47, 785–807. [Google Scholar] [CrossRef] [PubMed]
  63. Goldstrohm, A.C.; Hall, T.M.T.; McKenney, K.M. Post-transcriptional Regulatory Functions of Mammalian Pumilio Proteins. Trends in genetics: TIG 2018, 34, 972–990. [Google Scholar] [CrossRef] [PubMed]
  64. Lee, M.H.; Hook, B.; Pan, G.; Kershner, A.M.; Merritt, C.; Seydoux, G.; Thomson, J.A.; Wickens, M.; Kimble, J. Conserved regulation of MAP kinase expression by PUF RNA-binding proteins. PLoS genetics 2007, 3, e233. [Google Scholar] [CrossRef] [PubMed]
  65. Lee, M.H.; Wu, X.; Zhu, Y. RNA-binding protein PUM2 regulates mesenchymal stem cell fate via repression of JAK2 and RUNX2 mRNAs. Journal of cellular physiology 2020, 235, 3874–3885. [Google Scholar] [CrossRef]
  66. Goldstrohm, A.C.; Seay, D.J.; Hook, B.A.; Wickens, M. PUF protein-mediated deadenylation is catalyzed by Ccr4p. The Journal of biological chemistry 2007, 282, 109–114. [Google Scholar] [CrossRef]
  67. Friend, K.; Campbell, Z.T.; Cooke, A.; Kroll-Conner, P.; Wickens, M.P.; Kimble, J. A conserved PUF-Ago-eEF1A complex attenuates translation elongation. Nature structural & molecular biology 2012, 19, 176–183. [Google Scholar] [CrossRef]
  68. Kershner, A.M.; Kimble, J. Genome-wide analysis of mRNA targets for Caenorhabditis elegans FBF, a conserved stem cell regulator. Proceedings of the National Academy of Sciences of the United States of America 2010, 107, 3936–3941. [Google Scholar] [CrossRef]
  69. Whelan, J.T.; Hollis, S.E.; Cha, D.S.; Asch, A.S.; Lee, M.H. Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway. Journal of cellular physiology 2012, 227, 1235–1241. [Google Scholar] [CrossRef]
  70. Silva, I.L.Z.; Kohata, A.A.; Shigunov, P. Modulation and function of Pumilio proteins in cancer. Seminars in cancer biology 2022, 86, 298–309. [Google Scholar] [CrossRef]
  71. de la Roche, M.R.P.; Froats, M.; Bell, A.; McDonald, L.; Bolton, C.; Devins, R.; Hall, R.; Leclerc, J.; Istead, J.; Miron, M.; et al. Estimation of unregistered patients who left without being seen: At an urban mid-sized Canadian community emergency department. Canadian family physician Medecin de famille canadien 2021, 67, 114–120. [Google Scholar] [CrossRef]
  72. Vermani, L.; Kumar, R.; Senthil Kumar, N. GAPDH and PUM1: Optimal Housekeeping Genes for Quantitative Polymerase Chain Reaction-Based Analysis of Cancer Stem Cells and Epithelial-Mesenchymal Transition Gene Expression in Rectal Tumors. Cureus 2020, 12, e12020. [Google Scholar] [CrossRef] [PubMed]
  73. Gong, Y.; Liu, Z.; Yuan, Y.; Yang, Z.; Zhang, J.; Lu, Q.; Wang, W.; Fang, C.; Lin, H.; Liu, S. PUMILIO proteins promote colorectal cancer growth via suppressing p21. Nature communications 2022, 13, 1627. [Google Scholar] [CrossRef] [PubMed]
  74. Wickens, M.; Bernstein, D.S.; Kimble, J.; Parker, R. A PUF family portrait: 3’UTR regulation as a way of life. Trends in genetics: TIG 2002, 18, 150–157. [Google Scholar] [CrossRef] [PubMed]
  75. Ariz, M.; Mainpal, R.; Subramaniam, K. C. elegans RNA-binding proteins PUF-8 and MEX-3 function redundantly to promote germline stem cell mitosis. Developmental biology 2009, 326, 295–304. [Google Scholar] [CrossRef] [PubMed]
  76. Morgan, C.T.; Lee, M.H.; Kimble, J. Chemical reprogramming of Caenorhabditis elegans germ cell fate. Nature chemical biology 2010, 6, 102–104. [Google Scholar] [CrossRef]
  77. Bachorik, J.L.; Kimble, J. Redundant control of the Caenorhabditis elegans sperm/oocyte switch by PUF-8 and FBF-1, two distinct PUF RNA-binding proteins. Proceedings of the National Academy of Sciences of the United States of America 2005, 102, 10893–10897. [Google Scholar] [CrossRef] [PubMed]
  78. Xu, Z.; Zhao, J.; Hong, M.; Zeng, C.; Guang, S.; Shi, Y. Structural recognition of the mRNA 3’ UTR by PUF-8 restricts the lifespan of C. elegans. Nucleic acids research 2021, 49, 10082–10097. [Google Scholar] [CrossRef] [PubMed]
  79. Xu, J.; Jiang, Y.; Sherrard, R.; Ikegami, K.; Conradt, B. PUF-8, a C. elegans ortholog of the RNA-binding proteins PUM1 and PUM2, is required for robustness of the cell death fate. Development 2023, 150. [Google Scholar] [CrossRef] [PubMed]
  80. Vaid, S.; Ariz, M.; Chaturbedi, A.; Kumar, G.A.; Subramaniam, K. PUF-8 negatively regulates RAS/MAPK signalling to promote differentiation of C. elegans germ cells. Development 2013, 140, 1645–1654. [Google Scholar] [CrossRef]
  81. Subramaniam, K.; Seydoux, G. Dedifferentiation of primary spermatocytes into germ cell tumors in C. elegans lacking the pumilio-like protein PUF-8. Current biology: CB 2003, 13, 134–139. [Google Scholar] [CrossRef]
  82. Cha, D.S.; Datla, U.S.; Hollis, S.E.; Kimble, J.; Lee, M.H. The Ras-ERK MAPK regulatory network controls dedifferentiation in Caenorhabditis elegans germline. Biochimica et biophysica acta 2012, 1823, 1847–1855. [Google Scholar] [CrossRef] [PubMed]
  83. Lee, M.H.; Ohmachi, M.; Arur, S.; Nayak, S.; Francis, R.; Church, D.; Lambie, E.; Schedl, T. Multiple functions and dynamic activation of MPK-1 extracellular signal-regulated kinase signaling in Caenorhabditis elegans germline development. Genetics 2007, 177, 2039–2062. [Google Scholar] [CrossRef] [PubMed]
  84. Park, Y.; Gaddy, M.; Hyun, M.; Jones, M.E.; Aslam, H.M.; Lee, M.H. Genetic and Chemical Controls of Sperm Fate and Spermatocyte Dedifferentiation via PUF-8 and MPK-1 in Caenorhabditis elegans. Cells 2023, 12. [Google Scholar] [CrossRef] [PubMed]
Preprints 106297 g001
Figure 1. C. elegans germline and three distinct tumor models. (A) Schematics of adult C. elegans and its germline. Germ cells at the distal end of the germline, including GSCs, divide mitotically (yellow). As germ cells move proximally, they enter meiosis (green) and differentiate into either oocyte (pink) or sperm (blue). (B) Schematics of normal hermaphrodite germline and three tumor germline models resulting from glp-1 gain-of-function (gf), gld-1 loss-of-function (lf), or puf-8 loss-of-function mutation (lf). (C and D) Normal and tumor germlines. Wild-type (N2) and tumor germlines were stained with anti-HIM-3 (meiosis marker) antibodies and DAPI (DNA marker).
Figure 1. C. elegans germline and three distinct tumor models. (A) Schematics of adult C. elegans and its germline. Germ cells at the distal end of the germline, including GSCs, divide mitotically (yellow). As germ cells move proximally, they enter meiosis (green) and differentiate into either oocyte (pink) or sperm (blue). (B) Schematics of normal hermaphrodite germline and three tumor germline models resulting from glp-1 gain-of-function (gf), gld-1 loss-of-function (lf), or puf-8 loss-of-function mutation (lf). (C and D) Normal and tumor germlines. Wild-type (N2) and tumor germlines were stained with anti-HIM-3 (meiosis marker) antibodies and DAPI (DNA marker).
Preprints 106297 g001
Preprints 106297 g002
Figure 2. Notch signaling and its regulators. (A) Conserved Notch signaling pathways. Upon signaling, cleaved NICD translocates from the membrane to the nucleus. In the nucleus, NICD forms a tertiary complex with CSL and a co-activator (MSML, Mastermind-like protein), activating the expression of target genes. (B) C. elegans GLP-1/Notch signaling pathways. The DTC expresses GLP-1/Notch ligands (e.g., LAG-2) and employs GLP-1/Notch signaling to promote continued mitotic division of GSCs. (C) Positive and negative regulators of GLP-1/Notch signaling.
Figure 2. Notch signaling and its regulators. (A) Conserved Notch signaling pathways. Upon signaling, cleaved NICD translocates from the membrane to the nucleus. In the nucleus, NICD forms a tertiary complex with CSL and a co-activator (MSML, Mastermind-like protein), activating the expression of target genes. (B) C. elegans GLP-1/Notch signaling pathways. The DTC expresses GLP-1/Notch ligands (e.g., LAG-2) and employs GLP-1/Notch signaling to promote continued mitotic division of GSCs. (C) Positive and negative regulators of GLP-1/Notch signaling.
Preprints 106297 g002
Preprints 106297 g003
Figure 3. GLD-1 translational repressor and its regulators. (A) GLD-1 binds to the 5’ or 3’ UTRs of target mRNAs and generally represses their expression. (B) Positive and negative regulators of GLD-1.
Figure 3. GLD-1 translational repressor and its regulators. (A) GLD-1 binds to the 5’ or 3’ UTRs of target mRNAs and generally represses their expression. (B) Positive and negative regulators of GLD-1.
Preprints 106297 g003
Preprints 106297 g004
Figure 4. PUF-8 translational repressor and its regulators. (A) PUF-8 binds to the 3’ UTRs of target mRNAs and represses their expression. (B) The PUF protein family is widely distributed throughout eukaryotes. (C) Positive and negative regulators of PUF-8.
Figure 4. PUF-8 translational repressor and its regulators. (A) PUF-8 binds to the 3’ UTRs of target mRNAs and represses their expression. (B) The PUF protein family is widely distributed throughout eukaryotes. (C) Positive and negative regulators of PUF-8.
Preprints 106297 g004
Table 1. The glp-1 mutant alleles.
Table 1. The glp-1 mutant alleles.
Allele CGC stock Phenotype Ref.
bn18 DG2389 Temperature-sensitive loss-of-function mutant [11]
q224 JK1107 Temperature-sensitive loss-of-function mutant [12]
oz112 - A ligand-independent gain-of-function mutant characterized by the formation of germline tumors. [13]
ar202 GC833 A temperature-sensitive gain-of-function mutant characterized by the formation of proximal (Pro) germline tumors. This phenotype differs from that of the glp-1(oz112) mutants. The glp-1(ar202) mutants develop “Pro” germline tumors due to delayed initial meiotic entry during the L4 stage at the restrictive temperature. However, our genetic results revealed that additional mechanisms may induce the formation of germline tumors, even in the adult stage (Jones et al., unpublished results). [14]
Table 2. The gld-1 mutant alleles.
Table 2. The gld-1 mutant alleles.
Allele CGC stock Phenotype Ref.
op236 TG34 Fertile but hypersensitive to CEP-1/p53 mediated apoptosis. [51]
q485 JK3025 Sterile with germline tumors [37]
[37]
[37]
[37]
q268 JK3025 Sterile with germline tumors
q93 JK3934 Sterile with germline tumors
q343 JK1058 Small abnormal oocytes
Table 3. The puf-8 mutant alleles.
Table 3. The puf-8 mutant alleles.
Allele CGC stock Phenotype Ref.
ok302 JH1521 Fertile at 20°C but sterile at 25°C [81]
q725 JK3231 Fertile at 20°C, but some animals are sterile due to germline tumors at 25°C [82]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Exploring the Impact of Onobrychis cornuta and Veratrum lobelianum Extracts on C. elegans: Implications for MAPK Modulation, Germline Development, and Antitumor Properties

Qinghao Meng

et al.

,

2023

Somatic Evolution of Cancer: A New Synthesis

Ulfat Baing

et al.

,

2023

Zebrafish avatars: towards functional precision medicine in low-grade serous ovarian cancer

Charlotte Fieuws

et al.

,

2024

Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated